Interestingly, analysis of the intensity of KLK7 immunoreactivity revealed that metastatic melanoma tissues showed a higher average of cells with strong intensity compared to primary melanoma (13.5% versus 3.5%). This evidence concerns the gene KLK7 and metastatic melanoma.